The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Anti-VEGF targeting therapy in treatment of advanced renal cell cancer
Author(s): 
Pages: 528-531
Year: Issue:  7
Journal: JOURNAL OF INTERNATIONAL ONCOLOGY

Keyword:  肾肿瘤抗体单克隆受体蛋白质酪氨酸激酶类血管内皮细胞生长因子类;
Abstract: 晚期肾癌预后差而且对放化疗抗拒,免疫治疗仅使极少部分患者受益.血管内皮生长因子(VEGF)在肾透明细胞癌过量表达,表明它可以作为一个新的靶向治疗途径.经过临床试验证实,以VEGF为靶向通路的药物在治疗肾癌方面取得令人鼓舞的效果.
Related Articles
No related articles found